These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 29934245)
1. Design and synthesis of selenazole-substituted ritonavir analogs. Qiao J; Zhao C; Liu J; Du Y Bioorg Med Chem Lett; 2018 Aug; 28(14):2379-2381. PubMed ID: 29934245 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel HIV-1 protease inhibitors with pentacyclic triterpenoids as P2-ligands. Zhu M; Du XN; Li YG; Zhang GN; Wang JX; Wang YC Bioorg Med Chem Lett; 2019 Feb; 29(3):357-361. PubMed ID: 30580917 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir). Sham HL; Betebenner DA; Herrin T; Kumar G; Saldivar A; Vasavanonda S; Molla A; Kempf DJ; Plattner JJ; Norbeck DW Bioorg Med Chem Lett; 2001 Jun; 11(11):1351-3. PubMed ID: 11378352 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel conformationally restricted HIV protease inhibitors. Salituro FG; Baker CT; Court JJ; Deininger DD; Kim EE; Li B; Novak PM; Rao BG; Pazhanisamy S; Porter MD; Schairer WC; Tung RD Bioorg Med Chem Lett; 1998 Dec; 8(24):3637-42. PubMed ID: 9934485 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors. Baker CT; Salituro FG; Court JJ; Deininger DD; Kim EE; Li B; Novak PM; Rao BG; Pazhanisamy S; Schairer WC; Tung RD Bioorg Med Chem Lett; 1998 Dec; 8(24):3631-6. PubMed ID: 9934484 [TBL] [Abstract][Full Text] [Related]
7. Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands. Chen X; Kempf DJ; Sham HL; Green BE; Molla A; Korneyeva M; Vasavanonda S; Wideburg NE; Saldivar A; Marsh KC; McDonald E; Norbeck DW Bioorg Med Chem Lett; 1998 Dec; 8(24):3531-6. PubMed ID: 9934466 [TBL] [Abstract][Full Text] [Related]
8. Oximinoarylsulfonamides as potent HIV protease inhibitors. Yeung CM; Klein LL; Flentge CA; Randolph JT; Zhao C; Sun M; Dekhtyar T; Stoll VS; Kempf DJ Bioorg Med Chem Lett; 2005 May; 15(9):2275-8. PubMed ID: 15837308 [TBL] [Abstract][Full Text] [Related]
9. Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues. De Lucca GV; Kim UT; Liang J; Cordova B; Klabe RM; Garber S; Bacheler LT; Lam GN; Wright MR; Logue KA; Erickson-Viitanen S; Ko SS; Trainor GL J Med Chem; 1998 Jun; 41(13):2411-23. PubMed ID: 9632373 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors. Randolph JT; Huang PP; Flosi WJ; DeGoey D; Klein LL; Yeung CM; Flentge C; Sun M; Zhao C; Dekhtyar T; Mo H; Colletti L; Kati W; Marsh KC; Molla A; Kempf DJ Bioorg Med Chem; 2006 Jun; 14(12):4035-46. PubMed ID: 16504523 [TBL] [Abstract][Full Text] [Related]
11. Directed reductive amination of beta-hydroxy-ketones: convergent assembly of the ritonavir/lopinavir core. Menche D; Arikan F; Li J; Rudolph S Org Lett; 2007 Jan; 9(2):267-70. PubMed ID: 17217281 [TBL] [Abstract][Full Text] [Related]
12. The crystal structure of protease Sapp1p from Candida parapsilosis in complex with the HIV protease inhibitor ritonavir. Dostál J; Brynda J; Hrušková-Heidingsfeldová O; Pachl P; Pichová I; Rezáčová P J Enzyme Inhib Med Chem; 2012 Feb; 27(1):160-5. PubMed ID: 22146051 [TBL] [Abstract][Full Text] [Related]